Cerivastatin enhances the cytotoxicity of 5‐fluorouracil on chemosensitive and resistant colorectal cancer cell lines
Open Access
- 18 October 2002
- journal article
- Published by Wiley in FEBS Letters
- Vol. 531 (3) , 415-420
- https://doi.org/10.1016/s0014-5793(02)03575-5
Abstract
Cerivastatin is one of the synthetic 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase inhibitors used for the treatment and prevention of hypercholesterolaemia. The observation that patients receiving this drug had a lower incidence at cancer led to our interest in using it as a putative anticancer agent. In this study, we tested the cytotoxicity of cerivastatin on a panel of 5‐fluorouracil (5FU) sensitive and resistant cell lines in vitro. Cerivastatin was cytotoxic to both 5FU sensitive and resistant cells. Cerivastatin significantly augmented the cytotoxic effect of 5FU on drug sensitive (6–22‐fold) and resistant (229–310‐fold) cell lines. Cerivastatin and 5FU acted synergistically. Cerivastatin inhibited nuclear factor κB DNA binding activity. The enhancing effect of cerivastatin on 5FU was partially mevalonate pathway independent. Cerivastatin may allow successful 5FU therapy in chemoresistant patients.Keywords
This publication has 22 references indexed in Scilit:
- Chemoprevention of colorectal cancerAmerican Journal of Gastroenterology, 2002
- Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κBJournal of Clinical Investigation, 2001
- 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors and the Risk of CancerArchives of internal medicine (1960), 2000
- Antitumor activity and pharmacokinetics of a mixed-backbone antisense oligonucleotide targeted to the RIα subunit of protein kinase A after oral administrationProceedings of the National Academy of Sciences, 1999
- NF-κB Antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to Suppress Caspase-8 ActivationScience, 1998
- IEX -1L, an Apoptosis Inhibitor Involved in NF-κB-Mediated Cell SurvivalScience, 1998
- TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κBScience, 1996
- HMG-CoA reductase inhibitors: role in normal and malignant cellsCritical Reviews in Oncology/Hematology, 1996
- Regulation of the mevalonate pathwayNature, 1990
- Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdvances in Enzyme Regulation, 1984